Norman David Eansor serves as Executive at BIO-TECHNE Corp, where they oversee executive responsibilities. Since joining the company, Norman David Eansor has executed 58 insider transactions totaling $37.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 9, 2019 involved receiving (via award) 7,260 shares valued at $0.
Norman David Eansor currently holds 2,117 shares of BIO-TECHNE Corp (TECH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Norman David Eansor has been a net seller of TECH stock. They have purchased $250.0K and sold $37.4M worth of shares.
Norman David Eansor's most recent insider trade was on May 9, 2019, when they sold 7,260 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $180.14 |
| Discretionary |
| Aug 7, 2018 | TECH | $0 | Option Exercise | 1,199 | $N/A | Discretionary |
| May 4, 2018 | TECH | $164.9K | Sale | 1,136 | $145.19 | Discretionary |
| Jul 1, 2017 | TECH | $62.7K | Payment | 534 | $117.50 | Discretionary |
| Jul 1, 2016 | TECH | $59.8K | Payment | 533 | $112.24 | Discretionary |
| Jul 2, 2015 | TECH | $51.3K | Payment | 531 | $96.54 | Discretionary |
| Jul 2, 2015 | TECH | $0 | Option Exercise | 1,667 | $N/A | Discretionary |